Partnering

/Partnering

Plasticell collaborates with leading universities and industry partners to progress its therapeutic projects, facilitate drug discovery and improve product manufacturing in a variety of high value areas such as cell therapy, gene therapy, cancer immunotherapy and drug discovery.

Scroll below to explore a range of projects we have carried out with partners.

Plasticell and GSK have studied the role of drugs on platelet formation and also the regeneration of human tissues as part of a collaboration with our sister company Progenitor Therapeutics.

For more information please see press release 1news itempress release 2 and meeting poster.

Plasticell and JCR have developed expansion of mesenchymal stem cells used in cell therapy.

For more information please see press release.

Plasticell and UCB have collaborated on compound library screening for stem cell differentiation.

For more information please see press release.

Plasticell and Pierre Fabre have discovered plant extracts that stimulate human brown adipose tissue metabolism.

For more information please see press release.

Plasticell and Merck Millipore have developed and marketed stem cell research reagents.

For more information please see press release 1press release 2 and meeting poster.

Plasticell and Sigma have developed stem cell reporter cell lines using zinc finger nucleases.

For more information please see press release.

Plasticell and Hamilton have developed robotic solutions for stem cell culture.

For more information please see press release.

Plasticell and Molecular Devices have developed methods to increase growth factor secretion by stem cells.

For more information please see meeting poster.

Plasticell and the CGT Catapult have developed GMP-compliant expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m.

For more information please see press release.

Plasticell and A*STAR are collaborating to create genetically modified stem cell lines and products.

For more information, please see press release.

Plasticell and NHSBT have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.5m.

For more information please see press release.

Plasticell and the SNBTS have collaborated to produce red blood cells from stem cells. We have won government grants to fund projects valued at £1.3m.

Plasticell and LGC have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.5m.

For more information please see press release.

Plasticell and NIBSC have developed platform technologies for stem cell culture and screening. We have won government grants to fund projects valued at £1.1m.

For more information please see press release.

Plasticell and the University of Cambridge have collaborated to study novel biomaterials for stem cell expansion.

Plasticell and the University of Oxford have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m and Plasticell has funded two industrial PhD student.

For more information please see press release.

Plasticell and the University of Edinburgh identified a novel embryonic haematopoietic progenitor cell and have collaborated to produce red blood cells from stem cells. We have won government grants to fund projects valued at £1.3m.

For more information please see science paper, press release.

Plasticell and Imperial College have developed therapies for bone fractures. We have won government grants to fund projects valued at £1.3m and Plasticell has funded one industrial PhD student to develop models of the myometrium to study disorders leading to pre-term birth.

For more information please see press release.

Plasticell and UCL have developed platform technologies for stem cell culture and screening. We have won government grants to fund projects valued at £2.4m and Plasticell has funded three separate projects involving industrial PhD students.

For more information please see press release 1 and press release 2.

Plasticell and Kings College have collaborated on the commercialisation of hESC lines and pre-clinical testing of Plasticell’s therapeutic products

For more information please see press release 1press release 2

Plasticell and QMUL have developed stem cell reporter lines and protocols for generation of hepatocytes. We have won government grants to fund projects valued at £100,000 and Plasticell has funded one industrial PhD student.

Plasticell and NTU are collaborating to create genetically modified stem cell lines and products.

For more information, please see press release.

Plasticell and NUI Galway have collaborated to study cancer stem cells. Plasticell has funded one industrial PhD student in Galway.

For more information please see press release.

Plasticell and the Babraham Institute have collaborated to develop methods of stem cell culture.

Plasticell and the University of Strasbourg have developed protein and chemical cocktails for adult and embryonic stem cell differentiation. Plasticell has funded one industrial PhD student in Strasbourg.

Plasticell and Cell Guidance Systems have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m.

For more information please see press release.

Plasticell has collaborated with Progenitor Therapeutics to discover small molecule drugs that regenerate tissues of the human body.

For more information please see press release 1, press release 2, press release 3, press release 4meeting poster 1, meeting poster 2 and meeting poster 3.

Plasticell and Noveome (formerly Stemnion) have developed protocols for differentiation of amniotic fluid stem cells.

For more information please see press release.

Plasticell and Sphere Fluidics have developed high efficiency gene transduction for gene therapy.

For more information please see press release.

Plasticell and CellSpring have developed 3D models for high throughput cell-based screening.

For more information please see press release.

Plasticell and organovo have developed 3D bioprinted bone tissues.

For more information please see science paper.

Efficient, directed differentiation of stem cells to predetermined cell lineages remains a major challenge in the field of ESCs and IPSCs. We are pleased to partner with stem cell differentiation experts Plasticell to develop complementary products that address this rapidly growing market segment.

– Carl Schrott, Director of Marketing for Stem Cell Research Products, Sigma-Aldlrich